Spine Artificial Disc

April 21, 2022

Two-year Study Results: NuVasive Simplify Cervical Disc

Two-year Study Results: NuVasive Simplify Cervical Disc
Peer-reviewed results from the two-level multicenter FDA Investigational Device Exemption study reiterate disc's superiority to ACDF.
March 28, 2022

Milestone for Spine Innovations ESP Spinal Discs

Milestone for Spine Innovations ESP Spinal Discs
Over 20,000 of Spine Innovations' ESP cervical and lumbar spinal disc replacements have been implanted worldwide.
November 16, 2021

Treatment Milestone for Spineart’s Baguera C Disc

Treatment Milestone for Spineart’s Baguera C Disc
The 100th surgery has been performed in a 1-level and 2-level U.S. IDE clinical trial of the BAGUERA C Cervical Disc.
August 31, 2021

Study: Centinel Spine prodisc L Effectiveness

Study: Centinel Spine prodisc L Effectiveness
The study expands the evidence of the prodisc L disc replacement with results up to 21 years across a large patient cohort.
March 3, 2021

Orthofix Expects Continued Pressure in 1Q21

Orthofix Expects Continued Pressure in 1Q21
Although the company closed 2020 with strong sales from its spine franchise, it expects continued COVID-related declines through March 2021.

Member-Only Content

February 25, 2021

NuVasive Acquires Simplify Medical

NuVasive Acquires Simplify Medical
The company announced it acquired Simplify Medical for $150 million in cash along with future regulatory and sales milestones.
February 1, 2021

Synergy Disc Enrolls First Patient in Clinical Trial

Synergy Disc Enrolls First Patient in Clinical Trial
The multicenter study will examine efficacy of the Synergy Disc vs. anterior cervical discectomy and fusion in patients with degenerative disc disease.
November 12, 2020

Spine Innovations Spins Out of FH Ortho

Spine Innovations Spins Out of FH Ortho
Following acquisition of parent company FH Ortho, Spine Innovations is fully independent and dedicated to worldwide sales deployment of ESP disc replacements.
November 9, 2020

Orthofix Improvement Not Enough to Spur Growth

Orthofix Improvement Not Enough to Spur Growth
U.S. spinal sales drove Orthofix's sequential improvement in 3Q20 but were not enough to overcome lingering procedure volume declines due to COVID.

Member-Only Content

November 2, 2020

Olympus Acquires FH ORTHO

Olympus Acquires FH ORTHO
The acquisition underscores Olympus' plan to expand orthopedic minimally invasive surgery products, both organically and through mergers and acquisitions.
September 23, 2020

Spine Surgeon Reflects on Riding the Elective Surgery Rollercoaster

Spine Surgeon Reflects on Riding the Elective Surgery Rollercoaster
Eeric Truumees, M.D., First Vice President of NASS' Board of Directors, is optimistic that the online virtual annual meeting event in October will allow attendees to benefit from broader input in smaller doses.

Member-Only Content

September 1, 2020

AK Medical Grows Double-Digits in China

AK Medical Grows Double-Digits in China
The company grew in the high single digits for 1H20 as it benefited from provincial procurement tenders and the acquisition of Libeier.

Member-Only Content

August 24, 2020

AK Medical Expands 3D Printer Fleet to Meet Growing Demand

AK Medical Expands 3D Printer Fleet to Meet Growing Demand
The company expanded its 3D printing capacity by investing in eight GE Arcam EMB 3D printers to address the orthopedic needs of China's aging population.
August 6, 2020

Spineart Gains IDE Approval for BAGUERA C Trial

Spineart Gains IDE Approval for BAGUERA C Trial
The single-level trial will compare the BAGUERA C Cervical Disc Prothesis to another FDA approved arthroplasty device at up to 30 U.S. sites.
July 22, 2020

Centinel Spine’s prodisc L Gains Positive Coverage

Centinel Spine’s prodisc L Gains Positive Coverage
Based on udpated guidelines, nine commercial payers will begin covering TDR with prodisc L, representing an additional 9.2 million covered lives.
October 24, 2019

3 Questions on the Spine Reimbursement Environment

The spine market's evolving reimbursement landscape can be hard for device companies and surgeons to navigate. While at NASS, we asked reimbursement expert Kim Norton for a high-level view of the reimbursement shifts taking place today. Ms. Norton is Vice President of Reimbursement for Simplify Medical and serves as a consultant, including in reimbursement and payor relations for Aesculap.
July 19, 2019

Centinel Spine Announces prodisc C Clinical Trials

Centinel Spine received Investigational Device Exemption approval to initiate a two-level clinical trial with prodisc® C Vivo and prodisc C SK anterior cervical total discs.
June 18, 2019

Member Success Story: David Hovda, Simplify Medical

David Hovda, CEO of Simplify Medical, shares how he got from the U.S. Navy to orthopedics, lessons he learned along the way andhis outlook for the spine industry.
April 23, 2019

Orthofix M6-C Disc in First U.S. Patients Following PMA

Orthofix Medical announced first commercial U.S. implants of the M6-C cervical disc following FDA Premarket Approval of the device.
April 4, 2019

Orthofix M6-C Artificial Cervical Disc Study: Full 2-Year Data

Full 2-year outcomes from a U.S. IDE study of Orthofix Medical's M6-C artificial cervical disc demonstrated that disc replacement with the device is not inferior to treatment with ACDF.
March 14, 2019

AxioMed Gains CE Mark Approval

AxioMed was issued approval under the CE Mark for their viscoelastic cervical disc replacement.
February 5, 2019

FH Orthopedics: LP-ESP Disc Replacement Study Update

Study results indicate that FH Orthopedics' LP-ESP® Lumbar Prosthesis demonstrated excellent midterm follow-up results in total disc replacement at five years.
November 14, 2018

Simplify Medical Completes Cervical Disc IDE Trial

Simplify Medical completed enrollment and treatment of all patients in its U.S. Investigational Device Exemption pivotal trial evaluating the Simplify® Disc for two-level cervical disc replacement.
September 28, 2018

FDA Approves Update of Mobi-C Cervical Disc Labeling to Include 7-Year Clinical Results

FDA approved an update to the labeling for Zimmer Biomet's Mobi-C® Cervical Disc to include 7-year clinical results, showing the device to be statistically non-inferior in overall study success for 1-level use and statistically superior in overall study success for 2-level use.
September 17, 2018

Zimmer Biomet Launches Mobi-C in Japan

Zimmer Biomet has commenced launch of the Mobi-C® Cervical Disc in Japan.
August 8, 2018

UnitedHealthcare Covers Centinel Spine’s prodisc L

Centinel Spine announced UnitedHealthcare's positive medical policy for Lumbar Total Disc Replacement, granting 16MM patients access to the prodisc® L device.
August 8, 2018

Orthofix Reports 2Q18 Revenue

Orthofix posted 2Q18 revenue of US $111.5MM, +2.4% vs. 2Q17, with 1H18 revenue of $220.3MM, +4.1% vs. 1H17.

Member-Only Content

April 12, 2018

activL Lumbar Disc Study Results: Adjacent-Level Degeneration

Newly-published results from a 5-year study of Aesculap Implant Systems' activL® lumbar disc indicate that, in select patients, lumbar TDR is more effective than fusion at slowing the adjacent segment degenerative cascade.
March 16, 2018

Orthofix Enters Agreement to Acquire Spinal Kinetics

Orthofix entered into a definitive agreement to acquire Spinal Kinetics for US $45MM in cash plus up to $60MM in potential milestone payments. The transaction is expected to close in 2Q18.
February 27, 2018

Simplify Medical Receives 50th US Patent

Simplify Medical received its 50th U.S. patent, addressing the low-profile and anatomically-shaped design of its Simplify® cervical disc replacement.
February 9, 2018

Simplify Medical Closes Financing Totaling $44 Million

Simplify Medical closed an additional US $23.3MM in a Series B financing, for a total $44.3MM raised. Funds will support ex-U.S. commercialization and U.S. clinical trials studying the Simplify® cervical disc.
February 2, 2018

Zimmer Biomet Orthopaedic Revenue for 4Q17, 2017

ORTHOWORLD estimates Zimmer Biomet 4Q17 orthopaedic revenue of US $1,927.3MM, +2.9% from 4Q16, and 2017 revenue of $7,273.9MM, +2.7% vs. 2016.

Member-Only Content

December 22, 2017

Centinel Spine Completes prodisc Acquisition

Centinel Spine completed the acquisition of worldwide prodisc® total disc replacement assets from DePuy Synthes Products.
December 1, 2017

Globus Medical SECURE-C Disc vs. ACDF: 7-Year Follow-up

Results of seven-year clinical trial follow-up indicate superiority of Globus Medical's SECURE-C® cervical disc vs. ACDF in the treatment of cervical disc disease.
October 26, 2017

AxioMed Releasing Lateral Viscoelastic TDR

AxioMed introduced its lateral total disc replacement, for which first surgery completion is expected by year-end.
September 22, 2017

Spine Companies $100MM to $2BB: Strategic Activity Update

The majority of the spine market-just about 80%-is controlled by companies with annual spine revenue above $100 million. See a detailed breakdown of the top players.

Member-Only Content

August 2, 2017

Zimmer Biomet Orthopaedic Revenue for 2Q17

ORTHOWORLD estimates Zimmer Biomet 2Q17 orthopaedic revenue of US $1,816.0MM, +2.6% from 2Q16, and 1H17 revenue of $3,652.1MM, +3.7% vs. 1H16.

Member-Only Content

May 9, 2017

Aesculap Implant Systems Presents Long-term activL Study Data

Studies indicate that, at 5 years, the activ-L® Artificial Disc from Aesculap Implant Systems had a protective effect on the progression of degenerative disc disease at adjacent levels in 91.2% of patients. 
May 4, 2017

Globus Medical Reports 1Q17 Revenue

Globus Medical reported 1Q17 revenue of US $155.8MM, +11.9% vs. 1Q16. (U.S. $129.7MM, +1.6%; ex-U.S. $26.1MM, +123.4%) 

Member-Only Content

April 12, 2017

Clinical Trial Update: Simplify Medical’s Cervical Disc

The first patient has been treated in a pivotal clinical trial of Simplify Medical's Simplify® cervical disc, investigating use in two adjacent levels to treat degenerative disc disease.
December 22, 2016

AxioMed/DSM Extend Terms on Exclusive License Agreement

AxioMed modified terms of a previously-signed 15-year exclusive license agreement with DSM Biomedical, holder of the patent on polymer technology used in AxioMed's viscoelastic disc replacement. 
November 29, 2016

First AxioMed Viscoelastic Total Disc Implanted in Australia

AxioMed announced the first implantation of its viscoelastic Freedom cervical disc in Australia following the late 3Q16 regulatory approval of the device.
October 27, 2016

Positive Comparative Data from 7-Year Follow-Up Study of Mobi-C

Seven-year outcomes study data demonstrated statistical superiority of Zimmer Biomet's Mobi-C® Cervical Disc vs. 2-level ACDF in overall success. 
September 29, 2016

AxioMed Freedom Total Disc Approved In Australia

AxioMed received approval from the Therapeutic Goods Administration to market cervical and lumbar Freedom Viscoelastic Disc Replacement devices in Australia.
July 22, 2016

Medtronic, Zimmer Biomet Enter 2-level Disc and Robotic Markets

Since mid-May, both Medtronic and Zimmer Biomet have announced strategic moves in the 2-level cervical disc replacement and robotic surgery markets. In efforts to invigorate revenue growth, the two have focused on niche technologies that should expand their portfolios-but have yet to prove wide scale.
July 6, 2016

Two-year Clinical Results for Spineart’s Baguera C Cervical Disc

Study results indicate that patients treated with Spineart's BAGUERA® C cervical disc in 1- or 2-level arthroplasty exhibited good mobility at treated and adjacent levels, disc height restoration and evidence of adjacent level preservation.
June 7, 2016

Zimmer Biomet Acquiring LDR

Zimmer Biomet entered into a definitive agreement to acquire LDR for US $37/share in cash, for a transaction valued at ~$1.0BB with an expected 3Q16 close.
March 30, 2016

Independent Peer-Reviewed 5-Year Follow-Up: 2-Level Cervical Disc Replacement vs. ACDF

Results from 5-year clinical study comparing cervical total disc replacement (LDR's Mobi-C) with anterior discectomy and fusion to treat 2-level degenerative disc disease indicated overall success rates of 61% and 31% for cTDR and ACDF, respectively.
February 10, 2016

Five-Year Results of Mobi-C Cost Utility Analysis

Studies concluded that, for patients with 2-level degenerative disc disease, cervical total disc replacement appears to be highly cost-effective vs. ACDF, and supports greater quality of life at less cost.